Approval · Notice of Compliance 12633 · 2011
IFEX: Notice of Compliance 12633
Issued September 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12633
- Date
- September 14, 2011
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- 1. To align th Product Monograph with the Reference Safety Information (RSI) as per the Therapeutic Products Directorate's Advisement Letter dated February 8, 2010 2. To Update the Product Monograph to the new Format
- Therapeutic class
- Antineoplastic Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IFEX | Not yet assigned | — |
Medicinal ingredients
- IFOSFAMIDE 1 G per VIAL
- IFOSFAMIDE 3 G per VIAL